Trials / Completed
CompletedNCT02811536
Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 440 (actual)
- Sponsor
- Insel Gruppe AG, University Hospital Bern · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Comparison of OCTA to conventional imaging modalities for the diagnosis of eye diseases
Detailed description
Optical coherence tomography angiography (OCTA) is a new non-invasive imaging technique that employs motion contrast imaging to high-resolution volumetric blood flow information. OCTA compares the decorrelation signal between sequential OCT b-scans taken at precisely the same cross-section in order to construct a map of blood flow. At present, level 1 evidence of the technology's clinical applications doesn't exist. The investigators plan to compare OCTA as an imaging modality to conventional imaging modalities used in clinical routine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | optical coherence tomography angiography | Imaging with optical coherence tomography angiography |
Timeline
- Start date
- 2017-02-13
- Primary completion
- 2022-11-25
- Completion
- 2022-11-25
- First posted
- 2016-06-23
- Last updated
- 2022-11-29
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02811536. Inclusion in this directory is not an endorsement.